| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_005146ca04ff8413cedbc7f799fcfe74 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 |
| filingDate |
2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd162f3e4e950f4407e403a0db1bfdc8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84ada054c205f00061579e1a7fbd3578 |
| publicationDate |
2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2007070284-A |
| titleOfInvention |
Anti-diabetic complications |
| abstract |
PROBLEM TO BE SOLVED: To provide a novel drug effective for diabetic complications and a method for using the same. The present invention provides a drug comprising pyridoxal 5′-phosphate as an active ingredient. Also provided are methods for preventing and treating diabetic complications using pyridoxal 5'-phosphate. [Selection] Figure 2 |
| priorityDate |
2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |